Unanticipated synergies in the first meeting of Precision Medicine BioPharmaX
Image produced by the winner of the U-BIOPRED art contest.
The very first meeting of the Precision Medicine BioPharmaX was held today. Despite being in the middle of the holiday season, there was strong attendance and a good discussion.
We did have a brief discussion about the European Innovation Council’s Pathfinder call: Towards the Healthcare Continuum: technologies to support a radical shift from episodic to continuous healthcare. There is interest in developing a proposal. What was remarkable was how, despite the limited time, unexpected synergies emerged, such as considering the link between viral challenge studies and nasal epithelial cell 3D models.
How will this narrow the translational gap? When different disciplines and stakeholders come together as they do in BioPharmaX ecosystems, unanticipated synergies emerge. When you have a clear path toward making those synergies concrete it can result in rapid advancements that can be much faster than traditional incremental innovation.
The next step for Precision Medicine BioPharmaX is the development of a strategic plan for advancing precision medicine. This is meant to be a framework for deciding the direction and the types of projects the ecosystem should pursue.
What happens if we don’t do this? Strategic planning has been shown to improve organizational effectiveness, specifically in achieving goals. The big goal we hope to achieve is the realization of the benefits of achieving precision medicine.
We are seeking new members and partners for Precision Medicine BioPharmaX. If you think your organization would fit into this ecosystem let us know. email us.
